BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 18386001)

  • 1. Impact of IFNalpha2b upon pSTAT3 and the MEK/ERK MAPK pathway in melanoma.
    Wang W; Edington HD; Jukic DM; Rao UN; Land SR; Kirkwood JM
    Cancer Immunol Immunother; 2008 Sep; 57(9):1315-21. PubMed ID: 18386001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of signal transducers and activators of transcription 1 and 3 signaling in melanoma by high-dose IFNalpha2b.
    Wang W; Edington HD; Rao UN; Jukic DM; Land SR; Ferrone S; Kirkwood JM
    Clin Cancer Res; 2007 Mar; 13(5):1523-31. PubMed ID: 17332298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of high-dose IFNalpha2b on regional lymph node metastases of human melanoma: modulation of STAT5, FOXP3, and IL-17.
    Wang W; Edington HD; Rao UN; Jukic DM; Radfar A; Wang H; Kirkwood JM
    Clin Cancer Res; 2008 Dec; 14(24):8314-20. PubMed ID: 19088050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation Between Raf/MEK/ERK Signaling Pathway and Clinicopathological Features and Prognosis for Patients With Breast Cancer Having Axillary Lymph Node Metastasis.
    Shao GL; Wang MC; Fan XL; Zhong L; Ji SF; Sang G; Wang S
    Technol Cancer Res Treat; 2018 Jan; 17():1533034617754024. PubMed ID: 29529946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. STAT3 as a biomarker of progression in atypical nevi of patients with melanoma: dose-response effects of systemic IFNalpha therapy.
    Wang W; Edington HD; Rao UN; Jukic DM; Wang H; Shipe-Spotloe JM; Kirkwood JM
    J Invest Dermatol; 2008 Aug; 128(8):1997-2002. PubMed ID: 18305569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased expression of mitogen-activated protein kinase and its upstream regulating signal in human gastric cancer.
    Liang B; Wang S; Zhu XG; Yu YX; Cui ZR; Yu YZ
    World J Gastroenterol; 2005 Feb; 11(5):623-8. PubMed ID: 15655810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The BRAF(V600E) inhibitor, PLX4032, increases type I collagen synthesis in melanoma cells.
    Jenkins MH; Croteau W; Mullins DW; Brinckerhoff CE
    Matrix Biol; 2015 Oct; 48():66-77. PubMed ID: 25989506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High expression of Mcl-1L via the MEK-ERK-phospho-STAT3 (Ser727) pathway protects melanocytes and melanoma from UVB-induced apoptosis.
    Fukumoto T; Iwasaki T; Okada T; Hashimoto T; Moon Y; Sakaguchi M; Fukami Y; Nishigori C; Oka M
    Genes Cells; 2016 Feb; 21(2):185-99. PubMed ID: 26791143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clonorchis sinensis granulin promotes malignant transformation of human intrahepatic biliary epithelial cells through interaction with M2 macrophages via regulation of STAT3  phosphorylation and the MEK/ERK pathway.
    He Q; Pan X; Yin Y; Xu A; Yi X; Wu Y; Li X
    Parasit Vectors; 2023 Apr; 16(1):139. PubMed ID: 37095578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Over-expression of CKS1B activates both MEK/ERK and JAK/STAT3 signaling pathways and promotes myeloma cell drug-resistance.
    Shi L; Wang S; Zangari M; Xu H; Cao TM; Xu C; Wu Y; Xiao F; Liu Y; Yang Y; Salama M; Li G; Tricot G; Zhan F
    Oncotarget; 2010 May; 1(1):22-33. PubMed ID: 20930946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MEK inhibition affects STAT3 signaling and invasion in human melanoma cell lines.
    Vultur A; Villanueva J; Krepler C; Rajan G; Chen Q; Xiao M; Li L; Gimotty PA; Wilson M; Hayden J; Keeney F; Nathanson KL; Herlyn M
    Oncogene; 2014 Apr; 33(14):1850-61. PubMed ID: 23624919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High- and low-dose interferon alfa-2b in high-risk melanoma: first analysis of intergroup trial E1690/S9111/C9190.
    Kirkwood JM; Ibrahim JG; Sondak VK; Richards J; Flaherty LE; Ernstoff MS; Smith TJ; Rao U; Steele M; Blum RH
    J Clin Oncol; 2000 Jun; 18(12):2444-58. PubMed ID: 10856105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p21WAF1 expression induced by MEK/ERK pathway activation or inhibition correlates with growth arrest, myogenic differentiation and onco-phenotype reversal in rhabdomyosarcoma cells.
    Ciccarelli C; Marampon F; Scoglio A; Mauro A; Giacinti C; De Cesaris P; Zani BM
    Mol Cancer; 2005 Dec; 4():41. PubMed ID: 16351709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A specific mechanomodulatory role for p38 MAPK in embryonic joint articular surface cell MEK-ERK pathway regulation.
    Lewthwaite JC; Bastow ER; Lamb KJ; Blenis J; Wheeler-Jones CP; Pitsillides AA
    J Biol Chem; 2006 Apr; 281(16):11011-8. PubMed ID: 16464862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain Metastases Are Regulated by Immuno-inflammatory Signaling Pathways Governed by STAT3, MAPK and Tumor Suppressor p53 Status: Possible Therapeutic Targets.
    Zeller SL; Spirollari E; Dicpinigaitis AJ; Wainwright JV; Hanft SJ; Gandhi CD; Jhanwar-Uniyal M
    Anticancer Res; 2024 Jan; 44(1):13-22. PubMed ID: 38160007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-101 promotes nasopharyngeal carcinoma cell apoptosis through inhibiting Ras/Raf/MEK/ERK signaling pathway.
    Wu RS; Qiu EH; Zhu JJ; Wang JR; Lin HL
    Eur Rev Med Pharmacol Sci; 2018 Jan; 22(1):150-157. PubMed ID: 29364482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resistance to mitogen-activated protein kinase kinase (MEK) inhibitors correlates with up-regulation of the MEK/extracellular signal-regulated kinase pathway in hepatocellular carcinoma cells.
    Yip-Schneider MT; Klein PJ; Wentz SC; Zeni A; Menze A; Schmidt CM
    J Pharmacol Exp Ther; 2009 Jun; 329(3):1063-70. PubMed ID: 19258520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The roles of ERK and P38 MAPK signaling cascades on embryonic diapause initiation and termination of the silkworm, Bombyx mori.
    Fujiwara Y; Shindome C; Takeda M; Shiomi K
    Insect Biochem Mol Biol; 2006 Jan; 36(1):47-53. PubMed ID: 16360949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phospho-ERK staining is a poor indicator of the mutational status of BRAF and NRAS in human melanoma.
    Houben R; Vetter-Kauczok CS; Ortmann S; Rapp UR; Broecker EB; Becker JC
    J Invest Dermatol; 2008 Aug; 128(8):2003-12. PubMed ID: 18323787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of signal transducers and activators of transcription 3 and focal adhesion kinase by stromal cell-derived factor 1 is required for migration of human mesenchymal stem cells in response to tumor cell-conditioned medium.
    Gao H; Priebe W; Glod J; Banerjee D
    Stem Cells; 2009 Apr; 27(4):857-65. PubMed ID: 19350687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.